Top 20 Pharma and BioPharma Companies

Top 20 Pharma Report

Top 20 Pharma Report

It was quite a strange year for our top pharmas. A top 10 company spun off its innovative pharma unit, the biggest acquisition came from a company at the bottom of our list (Gilead's $11 billion purchase of Pharmasset and its hepatitis C pipeline), and the biggest launch came from a company that's not even in the Top 20: Vertex, which posted almost $1 billion in revenues in seven months for HCV treatment Incivek. The ranks were relatively stable, with minor shifts based on acquisition integrations. More often,  exchange rate fluctuations tweaked the results a bit, boosting companies that would otherwise look anemic or worse. The euro and krone both rose 5%, the British pound was up 4%, the yen was up 9%, and the Swiss franc blew up 18%. For USD-reporting companies, total revenues rose 6% to $301.5 billion. The days of double-digits are long gone . . .

—Gil Y. Roth Editor

Contributors Editor: Gil Y. Roth Associate Editor: Kristin Brooks Contributing Editor: Derek B. Lowe All profiles written by Gil Roth, except Astellas and Daiichi-Sankyo, by Kristin Brooks The Lowe Down capsules written by Derek Lowe (http://pipeline.corante.com) Pipeline information compiled by Kristin Brooks Revenue information compiled by Gil Roth Photo courtesy of Eli Lilly & Co.

Top 20 Pharma and BioPharma Companies

RANK COMPANY LOCATION SALES
1
Pfizer
66 Hudson Boulevard East, New York, New York, 10001-2192 $57.7 Billion
2
Novartis
Novartis Campus Basel, Baselstadt 4002 CH $47.9 Billion
3
Sanofi
46 Avenue de la Grande Armee Paris, 75017 France $42.8 Billion
4
Merck
Rahway, NJ $41.3 Billion
5
Roche
Grenzacherstrasse Switzerland, 4070 CH $37.1 Billion
6
GlaxoSmithKline
980 Great West Road Brentford, Middlesex TW8 9GS GB $35.6 Billion
7
AstraZeneca
1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge, Cambridgeshire CB2 0AA GB $33 Billion
8
Johnson & Johnson
1 Johnson and Johnson Plaza, New Brunswick, NJ 08903 US $24.4 Billion
9
Lilly
Lilly Corporate Center Indianapolis, Indiana 46285 US $22.6 Billion
10
Bristol Myers Squibb
3401 Princeton Pike Lawrence Township, NJ 08648 US $21.2 Billion
11
Takeda
Japan $17.3 Billion
12
Teva Pharmaceuticals
124 Dvora HaNevi'a St. Tel Aviv 6944020, Israel $16.7 Billion
13
Amgen
One Amgen Center Drive Thousand Oaks, CA 91320 US $15.6 Billion
14
Boehringer Ingelheim
900 Ridgefield Road, Ridgefield, CT 06877 $14.1 Billion
15
Bayer
Kaiser-Wilhelm-Allee Leverkusen, North Rhine-Westphalia 51373 DE $13.9 Billion
16
Novo Nordisk
Denmark $12.4 Billion
17
Astellas
2375 Waterview Dr Northbrook, Illinois 60062 US $12.3 Billion
18
Daiichi Sankyo
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo Tokyo, 103-8426 JP $11.3 Billion
19
Otsuka
2-16-4 Konan, Minato-ku, Tokyo 108-8241, Japan $9.9 Billion
20
Merck inc.
Frankfurter Strasse 250 64293 Darmstadt Germany $8.2 Billion
21
Gilead Sciences
333 Lakeside Drive Foster City, CA 94404 US $8.1 Billion
22
Mylan
1000 Mylan Boulevard Canonsburg, Pennsylvania 15317 US $6.1 Billion
23
Biogen
225 Binney Street Cambridge, MA 02142 US $4.8 Billion
24
CSL
1020 First Avenue King of Prussia, PA 19406 US $4.1 Billion
25
Allergan
Longphort House, Block J, Leeson Street Lower, Saint Kevin's, Dublin 2, D02 NY60, Ireland $1.6 Billion